四川科伦药业股份有限公司2025年度第二期科技创新债券发行结果的公告

Group 1 - The company has successfully issued the second phase of its technology innovation bonds for the year 2025, with the funds fully received on September 12, 2025 [2][4] - The total amount registered for the short-term financing bonds is RMB 4 billion, valid for two years from the date of the acceptance notice [2] - The funds raised from the bond issuance will be used to repay existing debts and supplement working capital [2] Group 2 - The second temporary shareholders' meeting for the year 2025 was held on September 15, 2025, with a total of 317 shareholders and proxies present, representing 600,498,166 shares, which is 37.7486% of the total voting shares [7][8] - No resolutions were rejected during the shareholders' meeting, and there were no changes to previous resolutions [4][11] - Legal opinions were provided by Beijing Zhonglun (Chengdu) Law Firm, confirming the legality and validity of the meeting's procedures and resolutions [13]